ReviewFrontiers in ophthalmology2026
Role of light in eye growth and light as a therapy for myopia control.
Review in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The escalating global prevalence of myopia-projected to affect nearly 5 billion individuals by 2050-represents one of the most pressing public health challenges of the 21st century. This comprehensive review synthesizes current evidence on light-mediated mechanisms governing ocular growth and their therapeutic explorations for myopia prevention and control. We examine how specific wavelengths, illuminance levels, and temporal exposure patterns influence emmetropization through chromatic aberration processing, photobiomodulation, and circadian regulation. This review provides a mechanistic framework for understanding how environmental light exposures shape refractive development and offers evidence-based guidance for implementing light-based interventions in clinical practice. As myopia transitions from a simple refractive error to a complex, multifactorial disease, these biologically informed approaches represent a paradigm shift toward prevention-focused management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.